BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kwan YH, Weng SD, Loh DHF, Phang JK, Oo LJY, Blalock DV, Chew EH, Yap KZ, Tan CYK, Yoon S, Fong W, Østbye T, Low LL, Bosworth HB, Thumboo J. Measurement Properties of Existing Patient-Reported Outcome Measures on Medication Adherence: Systematic Review. J Med Internet Res 2020;22:e19179. [PMID: 33034566 DOI: 10.2196/19179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Konstantinou P, Kasinopoulos O, Karashiali C, Georgiou G, Panayides A, Papageorgiou A, Wozniak G, Kassianos AP, Karekla M. A Scoping Review of Methods Used to Assess Medication Adherence in Patients with Chronic Conditions. Ann Behav Med 2021:kaab080. [PMID: 34570875 DOI: 10.1093/abm/kaab080] [Reference Citation Analysis]
2 Tigges-Limmer K, Stock Gissendanner S S, Schmid-Ott G, Wlost S, Gummert JF, Zittermann A. An Intervention Trial for Strengthening Medical Adherence after Heart Transplantation. Prog Transplant 2022;:15269248221089013. [PMID: 35361008 DOI: 10.1177/15269248221089013] [Reference Citation Analysis]
3 Basu S. Accurately estimating medication non-adherence through patient self-report: possibilities and limitation of a new scale. Curr Med Res Opin 2021;37:1349-51. [PMID: 34060950 DOI: 10.1080/03007995.2021.1937088] [Reference Citation Analysis]
4 Engler K, Vicente S, Mate KKV, Lessard D, Ahmed S, Lebouché B. Content validation of a new measure of patient-reported barriers to antiretroviral therapy adherence, the I-Score: results from a Delphi study. J Patient Rep Outcomes 2022;6:28. [PMID: 35347496 DOI: 10.1186/s41687-022-00435-0] [Reference Citation Analysis]
5 Islam MA, Nisa ZU, Almuzel AI, Al Afif HS, Al Rabia LH, Iqbal MS, Ishaqui AA, Iqbal MZ, Hossain MA, Haseeb A, Jamshed S, Naqvi AA, Kripalani S. Concurrent validity of the Arabic version of General Medication Adherence Scale using two validated indirect adherences measures in Saudi patients with non-communicable diseases. Saudi Pharm J 2021;29:874-8. [PMID: 34408547 DOI: 10.1016/j.jsps.2021.07.002] [Reference Citation Analysis]
6 Chen HF, Lei N, Xu YM, Luo L, Zhang XL, Lao BN, Tang F, Fu LZ, Liu XS, Wu YF. Is E-Version Transition of the Medication Adherence Scale Feasible for CKD Management? A Pilot Study. Patient Prefer Adherence 2021;15:1785-93. [PMID: 34429590 DOI: 10.2147/PPA.S323393] [Reference Citation Analysis]
7 Adeoye-olatunde OA, Curran GM, Jaynes HA, Hillman LA, Sangasubana N, Chewning BA, Kreling DH, Schommer JC, Murawski MM, Perkins SM, Snyder ME. Preparing for the spread of patient-reported outcome (PRO) data collection from primary care to community pharmacy: a mixed-methods study. Implement Sci Commun 2022;3. [DOI: 10.1186/s43058-022-00277-3] [Reference Citation Analysis]
8 Allaham K, Feyasa MB, Govender RD, Musa A, Alkaabi AJ, Elbarazi I, Alsheryani SD, Al Falasi RJ, Khan MA. Medication Adherence Among Patients with Multimorbidity in the United Arab Emirates. PPA 2022;Volume 16:1187-200. [DOI: 10.2147/ppa.s355891] [Reference Citation Analysis]
9 Wang Y, Wang X, Wang X, Naqvi AA, Zhang Q, Zang X. Translation and validation of the Chinese version of the general medication adherence scale (GMAS) in patients with chronic illness. Curr Med Res Opin 2021;37:829-37. [PMID: 33719815 DOI: 10.1080/03007995.2021.1901680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]